



EVALUATION OF A RAPID HUMAN 
IMMUNODEFICIENCY VIRUS TEST 
AT TWO COMMUNITY CLINICS IN 
KWAZULU-NATAL 
R Phili, E Vardas 
Objectives. To establish whether the Determine (Abbott, 
Tokyo, Japan) HIV antibody test is suitable as an on-site 
rapid HIV test at primary health care centres by 
determining its sensitivity and specificity compared with . 
the standard enzyme-linked immunoassay (ELISA) test. 
Design. Prospective field evaluation study of a rapid HIV 
test compared with an ELISA. 
Setting. KwaDabeka clinic and StMary's Hospital, urban 
primary health care clinics in the Durban western 
metropolitan area. 
Subjects. Women attending antenatal clinics and those 
presenting at onset of labour. 
Outcome measures. Performance of the rapid test versus 
conventional ELISA testing, sensitivity; specificity, feasibility 
of implementing the test at primary health care clinics, 
prevalence of HIV infection at study sites and its association 
with patient booking status. 
Results. A total of 323 specimens were tested from patients 
from two community clinics, KwaDabeka (N = 159) and St 
Mary's (N = 164). The overall HIV prevalence was 45.5%. 
There was a significant difference in HIV prevalence (P < 
0.001) between KwaDabeka (35.2%) and StMary's (55.5%). 
Of the participants 49.2% were from KwaDabeka clinic and 
50.8% from StMary's Hospital. Overall, HIV prevalence 
among unbooked participants was 43.0%, and among 
booked participants 46.3%. This was not statistically 
different (P = 0.612) between the two clinics. The rapid test 
showed a sensitivity and specificity of 100% when 
compared with a conventional diagnostic ELISA test. 
Conclusion. The Determine rapid HIV antibody test is 
sensitive, specific, easy to perform and provides a valuable 
method for HIV testing especially in settings with limited 
access to laboratory infrastructures and trained laboratory 
staff. 
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Diagnostic HIV testing in South Africa mainly entails the use of 
a series (two or three) of automated enzyme-linked 
immunoassays (ELISAs). 1 This may be problematic for under-
resourced institutions because of factors such as the long 
turnaround time for results, the large number of specially 
trained personnel involved in taking of blood specimens, 
specimen transportation, processing and dispatching of results, 
expensive equipment to process the specimens, hazards 
associated with transport of blood tubes and the fact that many 
of the individuals who have their blood collected do not come 
back for results. 
Since the introduction of the first enzyme immunoassay for 
the detection of antibodies against HIV in 1985/'3 the most 
widely used testing algorithm has been the screening of 
specimens with ELISA and repeat testing of reactive specimens 
with the more specific Western blot assay. Although this 
algorithm works well, in resource-poor settings it is difficult to 
implement because it requires skilled laboratory personnel and 
specialised equipment. With the progression of the HIV 
epidemic in South Africa, more affordable options are required 
for HIV testing. Rapid HIV tests can enable health care 
providers to supply definitive negative and preliminary 
positive results to patients at the time of testing. The 
advantages of rapid on-site testing, however, depend on 
whether tests are reliable and accurately reflect the HIV status 
of the individual. 
To date numerous investigations into the performance of 
rapid HIV kits have been performed, with varying findings.19 
Most of these investigations have centred on two important 
aspects, namely the specificity and sensitivity of the assay. 1 
Also there have been some doubts regarding the accuracy of 
HIV serological tests on patients infected with HIV subtypes of 
African origin,' since most of the available commercial tests are 
not manufactured in Africa and have not been evaluated 
extensively against HIV subtypes encountered in southern 
Africa. Most studies show that specific combinations of two or 
more different rapid HIV assays can provide results that are as 
reliable as those from the ELISA-Western blot combination.' 
According to the World Health Organisation (WHO), the 
choice of a testing strategy depends on the prevalence of HIV 
infection in the population and the presence or absence of HIV-
associated symptoms.' However, these recommendations do 
not specify which combination of tests should be used or 
provide data validating the sensitivity and specificity of the 
proposed algorithms under field conditions.' 
This study was done to establish whether the Determine 
(Abbott, Tokyo, Japan) rapid HIV antibody test canbe used for 
less expensive on-site rapid screening for the detection of HIV 
antibodies in primary health care settings by comparing its 
performance with that of an ELISA (Abbott Axsym HIV-1/2 go; 
Abbott, Delkenheim, Germany) test currently used widely in 
South African national laboratories for the diagnosis of HIV 
infection. 
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MATERIALS AND METHODS 
The study was approved by the Ethics Committee of the 
Faculty of Medicine, University of Natal, Durban. All the 
patients participated after having received appropriate 
information about the study and having signed written 
informed consent. 
Selection of Abbott Determine rapid test 
Choice of this particular rapid test was based on the fact that it 
has given satisfactory results in other settings,' it is able to 
discriminate between HIV-1 and HIV-2, it is readily available 
and reasonably priced, it can be performed using a variety of 
specimens (plasma or whole blood), and it has a long shelf life. 
Study sites 
Two primary health care facilities which are existing Medical 
Research Council (MRC) study sites were chosen for this study. 
KwaDabeka clinic is a 24-hour urban health care centre, which 
caters for a population of about 52 000 people from the 
townships of Clermont and KwaDabeka outside Durban. 
KwaDabeka clinic is the only facility in that area which offers 
antenatal care and delivery facilities for this population. 
The second site, StMary's Hospital, is a district hospital 
situated about 20 km from K waDabeka clinic. It serves as the 
referral centre for KwaDabeka clinic and other surrounding 
clinics on the outskirts of Pinetown and the inner west of 
Durbnn. 
Subjects 
Initial sample size calculations were based on the current 
estimated HIV prevalence level in KwaZulu-Natal of 32% (1998 
antenatal clinic survey, Department of Health). We wished to 
show the sensitivity of a rapid test of at least 97% with a 95% 
confidence interval (CI): 92 - 99%. Based on calculations with 
EPI-Info version 6, we calculated that we would require 313 
women for a rapid test of 97% sensitivity compared with the 
standard 100% sensitivity on the ELISA. The power of the 
study was therefore quite low enabling us to show only a 10% 
difference between a rapid test and the standard ELISA. 
All women presenting at onset of labour from December 
1999 to June 2000 who agreed to participate in the study at 
both clinics were enrolled until we had the total sample size 
required. 
Study procedure 
Women presenting in labour and at the antenatal care clinic 
who did not know their HIV status were offered free HIV 
counselling and testing. This was followed by collection of 
blood from the consenting participants into ethylene-
diaminetetraacetic acid (EDTA) anticoagulated test tubes. The 
Determine rapid HIV antibody test was then performed and 
the results recorded. Preliminary results were given to the 
participants and they were told to return on a designated day 
for results of a confirmatory ELISA test. Blood specimens were 
then centrifuged and the plasma frozen at -20°C. 
Confirmatory testing on these specimens was performed at the 
virology laboratory at King Edward VIII Hospital, Durban, 
using the Abbott Axsym automated microparticle ELISA 
system (MELISA). Testing was done in accordance with the 
manufacturer's instructions. 
ANALYSIS OF RESULTS 
The results were analysed using the statistical analysis system 
(SAS version 6.12, Carry, NC) and SPSS version 9.0 
computerised statistical packages. Univariate analysis was 
done using the two-sided Pearson's chi-square test of 
significance. The sensitivity of the rapid test was expressed as 
the ratio of the patients testing positive by the rapid test over 
those testing positive by confirmatory test. The specificity was 
calculated as the ratio of the negative rapid tests over the 
negative ELISA confirmatory test. The positive and negative 
predictive values were calculated as the proportions of patients 
with positive and negative rapid tests that were truly positive 
and truly negative (i.e. by confirmatory test). 
RESULTS 
Of the total323 specimens tested, 147 (45.5%) tested positive 
with both the rapid test and the ELISA, and 176 (54.5%) were 
negative by both methods (Table I). The sensitivity of the rapid 
test compared with the ELISA was 100%. There were no 
discordant results among the 147 HIV-positive patients or the 
174 HIV- negative patients between the two tests. Since there 
was no discordance between the rapid test and the ELISA 
confirmatory test in this small pilot study, the sensitivity and 
the negative predictive values were equal. Similarly, the 
specificity and the positive predictive values were also equal. 
However, it should be noted that both the positive and 
negative predictive values are dependent on the population 
disease prevalence, which is high in South Africa for HIV 
compared with developed countries. 
Of the 323 patients tested, 159 (49.2%) were from 
Table I. Comparison of the rapid test strategy with the ELISA test 
strategy (N = 323) 
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KwaDabeka clinic and 164 (50.8%) from StMary's (Table II). 
The overall prevalence of HIV infection at these two sites was 
45.5%. There was a significant association between the HIV 
status and site (P < 0.0003), with the rate higher at StMary's 
than at KwaDabeka clinic (Fig. 1). The high prevalence could 
be that many patients who came for testing at StMary's 
Hospital were potential high-risk patients seeking inclusion in 
a concurrent study conducted at this site. There was no 
significant association between the booking status of the 
participants and the sites (P = 0.291), with StMary's having a 
higher number of booked patients (52.9%), than KwaDabeka 
clinic (47.1 %). 
The prevalence of HIV between booked and unhooked 
patients showed no major difference, with a rate of 43% among 
the unhooked group, i.e. women enrolled at the onset of labour, 
and 46.3% among those enrolled at antenatal clinics 







t: 60 Q) 




H IV-positive HIV-negative 
Fig. 1. Prevalence of HIV at KwaDabeka clinic and StMary's 
Hospital. 
DISCUSSION 
Rapid tests with immediate results are appropriate for HIV 
screening in primary health care settings in South Africa. 
People who test negative are able to learn their status and 
receive counselling in a single visit, thereby reducing the 
psychological stress of waiting for results, and saving time and 
resources. Provision of preliminary positive results increases 
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(%) No. (%) 
35.2 44 55.7 
55.5 35 44.3 
45.5 79 24.5 
the number of infected people who learn their infection status 
and can be referred for medical treatment and other prevention 
services. This is particularly important in the light of the 
possible introduction of antiretrovirals by the South African 
government to prevent mother-to-child transmission (MTCT) 
of HIV infection. Although there was no significant association 
between the patient booking status and the prevalence of HIV 
infection in this study, it is generally accepted that unhooked 
mothers are at higher risk and are more likely to have sexually 
transmitted diseases' such as syphilis among others. Therefore 
it is generally accepted that these high-risk women should be 
offered HIV testing, and introduction of a rapid test will be of 
great significance in the management of these patients.10 
The sensitivity and specificity of the Determine rapid assay 
are comparable to those of a conventional ELISA. A negative 
test does not require further testing, and counselling can be 
provided at the initial visit. 
Wilkinson et al.5 used a prospective comparison of two 
testing strategies, namely double rapid test on site versus 
central ELISA-based testing. However, a single rapid test 
seems to be an ideal solution for use in resource-poor settings 
as it provides a cheaper alternative than a double testing 
strategy. Double rapid tests may increase the costs, and if two 
tests are done, they may be more expensive than conventional 
ELISAs, which are performed in batches in a laboratory. 
The Determine test strip is. essentially a three-step process 
and the results are read visually and available in 15 minutes. A 
built-in control ensures the test validity and essentially no 
specialised equipment is required. The benefits of rapid testing 
are greatest for settings that serve a population with a high 
prevalence of HIV. 
This study shows that the use of the Determine rapid test 
yields results that are as accurate as those of the conventional 
ELISA test. This was very useful at the two clinics where these 
MTCT studies were being performed. The test was a 
straightforward procedure that could be performed easily by 
the nursing staff and other personnel with minimum training. 
Rapid tests will undoubtedly enhance the implementation of 
MTCT programmes at various institutions and could save 
money and other resources, which would otherwise be wasted, 
should these programmes be introduced in South Africa. 
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THE RADIOLOGICAL OUTCOME 
OF LUMBAR SPINAL FUSION 
USING A SOUTH AFRICAN-
DEVELOPED DYNAMIC SPINAL 
FIXATION SYSTEM 
Guillaume du Toit, Gert Vlok 
Objectives. To investigate the radiological outcome of the use 
of a new Cape Town-developed spinal fixation system. 
Design. One hundred and fifty-five patients underwent 
posterior lumbar spinal fusions with this fixation system and 
autogenous bone graft more than a year ago. Of these 121 
were available for radiological follow-up. 
Setting. Spinal pedicle fixation systems are in common use in 
spinal fusion surgery. Most systems use rigid screws with a 
high rate of implant failure. 
In South Africa most spinal implants are imported and 
expensive, and this prompted the development of a locally 
Constantiaberg Mediclinic, Cape Town 
Guillaume du Toit, MB BCh, FRCS (Canada) 
Department of Orthopaedic Surgery, University of Stellenbosch, Tygerberg, W Cape 
Gert Vlok, MB ChB, MMed (Ortop), FCOrth 
manufactured dynamic spinal fixation system with the aim of 
producing a cheaper and more effective system with a lower 
risk of implant failure. 
Outcome measures. A visual assessment of 1-year post-surgery 
radiographs by a qualified independent observer looking 
particularly at the rate of fusion and the incidence of implant 
failure. 
Results. Bone fusion rates were comparable to all other 
pedicle fixation systems but implant failure rates were 
considerably less than in systems using rigid screws and 
more comparable to a similar dynamic spinal fixation system. 
Conclusions. This spinal fixation system is safe and effective in 
aiding bone fusion. It has a low rate of implant failure and is 
currently cheaper than all imported spinal fixation systems. It 
has therefore achieved the objectives that prompted its 
inception. 
5 Afr Med J 2002; 92: 821-825. 
The efficacy of lumbar pedicle screw fixation as an adjunct 
particularly in long lumbar spinal fusions is now well 
accepted.1 This success is reflected in the multitude of such 
devices developed over the last decade. Early plate and screw 
constructs were soon superseded by more versatile rod and 
screw systems. Initially all fixation systems employed rigid 
screws which necessitated very accurate rod contouring to 
accommodate sagittal coronal and torsional distortions of the 
spine. Failure to achieve a precise fit between the screw and the. 
rod would result in preloading of the system with the risk of 
subsequent failure. Even where an adequate fit is obtained 
there is still a significant incidence of instrumentation failure'-17 
such as screw breakage, rod breakage or failure at the bone-
metal interface with loosening of the screws in bone ( Table I). 
Recognising the inherent defects in implant design von 
Strempel et a/. 18 developed a unique implant (segmental spinal 
correction system) whereby the head and shank of the screw 
are connected via a hinge to allow permanent uni-axial 
articulation- a so-called dynamic fixation system. At first 
glance this seems contradictory since the purpose of the 
implant is to achieve rigid fixation. Biomechanical testing in 
von Strempel's own laboratory' as well as in an independent 
laboratoryi' showed that the dynamic system was as rigid in 
vitro as one utilising fixed screws. 
A review of patients treated with this method of fixation 
showed that the bony fusion rate was as good as with any rigid lfJI 
system, and importantly that the instrumentation failure rate 
was considerably reduced.20 ' 
This system has the further advantage that precise rod 
contouring to achieve a perfect fit between the rod and the 
screw head is largely eliminated by the perpetual mobility of 
the screw head which readily accommodates non-
